Adverse skin reactions following percutaneous bone conduction implant surgery using the linear incision technique with and without subcutaneous tissue reduction

Abstract

Of the 289 bone conduction implants, 25 were implanted in children, 220 in adults, and 44 in elderly. Implant loss occurred in 2.8% of all cases: 8.0% in children, 2.3% in adults, and 2.3% in the elderly. Skin overgrowth was seen in 4.2%: 4% in children, 4.8% in adults, and 3.5% in the elderly. No differences were observed in the amount of adverse skin reactions (16.8% vs 14.7%) or skin overgrowth (4.6% vs 2.9%) between the surgical techniques. There was no difference in adverse skin reactions if the patient had a retroauricular incision (14.4% with vs 17.8% without prior incision).

Clinical evaluation of a new laser‐ablated titanium implant for bone‐anchored hearing in 34 patients: 1‐year experience

“…The introduction of wider diameter implants, providing an enlarged bone‐implant interface and thus a larger interface for osseointegration, has resulted in up to 3‐year survival rates of >96% in healthy adult patients . Despite the low incidence of implant loss in healthy adults, in certain patient groups, ie patients with compromised bone quality or in children, the incidence is much higher, varying between 3.5%‐10.5% even with these wider diameter implants . To improve implant survival in these populations as well, further optimisation of implant material, design and surgical technique remains needed.…”

“…[1][2][3] Despite the low incidence of implant loss in healthy adults, in certain patient groups, ie patients with compromised bone quality or in children, the incidence is much higher, varying between 3.5%-10.5% even with these wider diameter implants. [4][5][6] To improve implant survival in these populations as well, further optimisation of implant material, design and surgical technique remains needed.…”

Nonsurgical Management of Single-Sided Deafness: Contralateral Routing of Signal

“…Furthermore, such solutions do not require the long-term management typically associated with surgical solutions. [37][38][39][40] Given their relative low cost and noninvasive nature, CROS hearing aids should be the first option considered in management of SSD.…”

Provision of bone conduction hearing implants in England in adults and children: a review of Hospital Episode Statistics data 2012–2021

“…It is used in those individuals with congenital or acquired absence of the ear canal, or those with pathology preventing effective sound conduction. [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18] Bone conduction hearing implants consist of two parts: a processor device that converts sound to a digital signal, and a mount or attachment connecting this device to the overlying skin or directly to the temporal bone. The processor comprises a microphone, amplifier, digital processor and transducer.…”

“…However, the active processor sitting directly on the bone has reduced this problem, and, as no osseointegration is required, it only requires one surgical stage. 4,5,7,10,12,18,19,21,23 Although there are many examples in the literature of patient-related outcomes with regard to bone conduction hearing implants, 1,2,[4][5][6][7][8][9][10]13,16,18 overall, the findings are from individual institutions; there have been no previously published data on the total number of bone conduction hearing implantations performed in England as a whole.…”